The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 09 2026 for Hemal Vasantrai Mehta
09-सितंबर-2026
डाउनलोड पीडीएफ़
Sudarshan Pharma
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 09 2026 for Hemal Vasantrai Mehta